Vicore Pharma Holding AB (publ) (VICO.ST)
SEK 7.77
(1.17%)
SEK 7.77
(1.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -249.58 Million | -299.91 Million | -265.17 Million | -119.93 Million | -86.99 Million | -33.03 Million |
| Net Income | -310.94 Million | -290.72 Million | -294.81 Million | -149.53 Million | -94.01 Million | -41.58 Million |
| Depreciation & Amortization | 65.97 Million | 3.61 Million | 3.59 Million | 3.53 Million | 1.33 Million | 7000.00 |
| Deferred income taxes | -6900.00 | -4872.00 | 1563.00 | -8200.00 | -4588.00 | - |
| Stock-based compensation | 6.9 Million | 4.87 Million | -1.56 Million | 8.19 Million | 4.58 Million | 1.99 Million |
| Change in working capital | -10.64 Million | -20.94 Million | 27.07 Million | 22.68 Million | 3.55 Million | 8.03 Million |
| Other non-cash items | 6.02 Million | 8.13 Million | -1.02 Million | 3.38 Million | 2.11 Million | 506 Thousand |
| Investing Cash Flow | -144.45 Million | 74 Million | -7 Million | 4 Million | -77.14 Million | 15.03 Million |
| Investments in PPE | -199.03 Million | -3 Million | - | -3 Million | -147 Thousand | -2 Million |
| Acquisitions | - | - | - | 3 Million | - | 20.25 Million |
| Investment purchases | -199.03 Million | - | -77 Million | -70 Million | -77 Million | -3.22 Million |
| Sales/Maturities of investments | 54.58 Million | 77 Million | 70 Million | 77 Million | - | 2 Million |
| Other Investing Activities | 199.03 Million | 74 Thousand | -7000.00 | -3 Million | -77 Thousand | -2 Million |
| Financing Cash Flow | 470.85 Million | 187.04 Million | 318.18 Million | 176.96 Million | 127.04 Million | 218.67 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 470.91 Million | 187.29 Million | 336 Million | 187.55 Million | 134.82 Million | 232.42 Million |
| Other Financing Activities | -63 Thousand | 187.04 Million | -17.81 Million | -10.58 Million | -7.78 Million | -13.74 Million |
| Accounts receivables | -2.69 Million | -1.59 Million | -340 Thousand | -3.86 Million | 234 Thousand | -1.27 Million |
| Accounts payables | -7.95 Million | -19.34 Million | 27.41 Million | 26.54 Million | 3.32 Million | 9.31 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -6.36 Million | - | - | - | - | - |
| Cash at beginning of period | 256.8 Million | 294.19 Million | 248.61 Million | 187.58 Million | 224.68 Million | 24.01 Million |
| Cash at end of period | 333.62 Million | 256.8 Million | 294.19 Million | 248.61 Million | 187.58 Million | 224.68 Million |
| Capital Expenditure | -199.03 Million | -3 Million | - | -3 Million | -147 Thousand | -2 Million |
| Effect of forex changes on cash | - | 1.48 Million | -431 Thousand | - | - | - |
| Net cash flow / Change in cash | 76.81 Million | -37.39 Million | 45.58 Million | 61.03 Million | -37.1 Million | 200.66 Million |
| Free Cash Flow | -448.62 Million | -302.91 Million | -265.17 Million | -122.93 Million | -87.14 Million | -35.03 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -56.32 Million | 31.71 Million | -310.94 Million | -111.89 Million | -65.05 Million | -69.79 Million |
| Depreciation & Amortization | 839 Thousand | 840 Thousand | 65.97 Million | 51.39 Million | 840 Thousand | 839 Thousand |
| Deferred income taxes | - | - | -6900.00 | -1500.00 | -841.8 Thousand | -840.6 Thousand |
| Stock-based compensation | 5.2 Million | 1.7 Million | 6.9 Million | 1.5 Million | 1.8 Million | 1.6 Million |
| Change in working capital | 6.73 Million | -4.65 Million | -10.64 Million | -8.92 Million | 14.73 Million | -1.9 Million |
| Other non-cash items | -5.85 Million | 1.52 Million | 6.02 Million | 1.95 Million | 14.96 Million | 2.65 Million |
| Investing Cash Flow | -24.81 Million | 70 Million | -144.45 Million | 50 Million | -199.03 Million | -4.58 Million |
| Investments in PPE | 49.55 Million | - | -199.03 Million | -199.03 Million | - | - |
| Acquisitions | - | - | - | -50 Thousand | - | - |
| Investment purchases | -64.81 Million | - | -199.03 Million | 199.03 Million | -199.03 Million | - |
| Sales/Maturities of investments | 40 Million | 70 Million | 54.58 Million | 50 Million | 4.58 Million | -4.58 Million |
| Other Investing Activities | -24.81 Million | 70 Million | 199.03 Million | 50 Thousand | -4.58 Million | - |
| Financing Cash Flow | 5000.00 | - | 470.85 Million | - | 325.89 Million | 145.01 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5000.00 | - | 470.91 Million | - | 346.3 Million | 154.1 Million |
| Other Financing Activities | 5000.00 | - | -63 Thousand | - | -20.4 Million | -9.08 Million |
| Accounts receivables | 17.49 Million | -15.37 Million | -2.69 Million | -3.83 Million | 6.31 Million | -176 Thousand |
| Accounts payables | -10.76 Million | 10.71 Million | -7.95 Million | -5.08 Million | 8.41 Million | -1.73 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -10.76 Million | - | - | - | - | - |
| Cash at beginning of period | 431.16 Million | 333.62 Million | 256.8 Million | 351.08 Million | 259.59 Million | 183.62 Million |
| Cash at end of period | 358.65 Million | 431.16 Million | 333.62 Million | 333.62 Million | 351.08 Million | 259.59 Million |
| Capital Expenditure | 49.55 Million | - | -199.03 Million | -199.03 Million | - | - |
| Effect of forex changes on cash | 1.84 Million | 4.46 Million | - | - | - | 4.58 Million |
| Net cash flow / Change in cash | -72.51 Million | 97.54 Million | 76.81 Million | -17.46 Million | 91.49 Million | 75.96 Million |
| Free Cash Flow | - | 23.08 Million | -448.62 Million | -266.5 Million | -35.36 Million | -69.05 Million |
002004
MAGE
FMNL
MEI
SHAH
QCKSF